Biochemical and pharmacologic effects of alpha-methyltyrosine in man - Wikidata - awgldk - TriplyDB

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

http://www.wikidata.org/entity/Q28254373

about

Alpha-methyltyrosine in the management of phaeochromocytoma Modification of the tremorigenic activity of physostigmine Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.Phaeochromocytoma with myocarditis managed with alpha-methyl-p-tyrosine.Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.Anaesthesia for phaeochromocytoma.Sleep and behavioral changes possibly reflecting central receptor hypersensitivity following catecholamine synthesis inhibition in man.Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.An unusual cause of toe necrosis.Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide.Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report.Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.An animal model for psychopharmacological research with relevance to psychiatry.Development of tolerance to the behavioral depressant effects of alpha-methyltyrosine.Brain catecholamines and human sleep.Management of anaesthesia for phaeochromocytoma.

P2860

Q24563467-4D5E36C5-1B16-4655-9CF8-81A575480ADC Q28363698-9EEDE13C-E868-44D1-9A4F-0C846DE353EA Q28366413-8098E9CC-E752-4DF7-A2BC-A337C2E697EC Q33894434-984FCC63-B863-4915-94AC-DC27B919ABE6 Q34272903-8F6AD2D4-5F6E-4C1C-BF04-32B4F04E1DE3 Q34279718-CBECC0BD-D756-4567-9C81-C6BEACED193D Q35551216-024565C1-0923-441F-B23F-2EBC7DA7588A Q35601193-02F19F93-4ECE-4C17-A924-1F4369D9AF9A Q36738339-A008126B-C16C-40BF-8733-0C8BECD469F0 Q36811445-33E3FF49-8143-4E66-9159-3057FDDED0EC Q38865477-2D3D33A5-7CB1-4624-BF66-C72C8676F0E6 Q39525348-DD4B93EE-348C-4DA9-8E43-C7A06F3246DA Q40095910-77DADEC8-202B-47A5-82BB-A5AB8EDF0D60 Q40535604-52E00C24-5F62-4546-AD80-54B809BF5BC2 Q40888441-BEEE08A6-791E-48C0-B757-C5060FE92844 Q43872629-500F38D6-E450-4FFC-9BE0-4F27C0086E2D Q47654066-4E976CDE-A2F9-4F33-970B-39FA4733B293 Q48181816-4EA738F5-81FC-4807-BB8F-4E9AA8F4AC7F Q48669210-B75D3FAF-C266-438F-B253-808A26C72E2E Q49144398-86970D72-4452-475C-88CC-C2D25324A44D Q51121388-7A7C3BD3-3334-41FF-91C2-860B267B1D19 Q52735823-0471B3D3-5D54-4F51-BF38-298AE58995E7

P2860

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

http://www.wikidata.org/entity/Q28254373

description

1968 nî lūn-bûn

@nan

1968 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1968 թվականի մարտին հրատարակված գիտական հոդված

@hy

1968年の論文

@ja

1968年論文

@yue

1968年論文

@zh-hant

1968年論文

@zh-hk

1968年論文

@zh-mo

1968年論文

@zh-tw

1968年论文

@wuu

name

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@ast

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@en

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@nl

type

label

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@ast

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@en

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@nl

prefLabel

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@ast

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@en

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@nl

P1433

Q28254373-02EEA43F-9922-406B-82EF-8EF319A9B9FD

P1476

Q28254373-47BC1408-2219-4939-8B17-5531D693A404

P2093

Q28254373-87C5143B-3466-445C-9BE0-C5BA5CE8199B

Q28254373-9F9AA76F-1B55-4325-BA28-A4C0947D11F2

Q28254373-CD73F4C2-43C0-41A1-BE15-66126AC1777A

Q28254373-D8FC0392-658A-4DF4-A62B-502728E45455

P2860

Q28254373-2699A297-46EA-4555-AA6B-9D86570EC42C

Q28254373-2AF2D3F2-42DB-4F3D-8E06-DDB43B116A64

Q28254373-51FB812D-EA53-4191-8DE8-1E2798912B6C

Q28254373-8601EFDE-A6A6-414D-BEB4-01EDD0A07043

Q28254373-D56D7669-9825-4248-9595-6A6CCA5DEEF3

P304

Q28254373-CDD56AEF-AD19-4FE7-8F0F-A050646D7E3F

P31

Q28254373-12243342-F52D-4717-A47F-64411E0F3800

P356

Q28254373-E6B06E4B-2687-479B-836D-43516B05D62A

P407

Q28254373-D1F7BCD1-505A-45F5-87E6-2EF663D8422A

P433

Q28254373-3D38578E-85B7-45B5-BFFF-9DE773DB46FC

P478

Q28254373-FF3FDBC5-2B0E-4260-A516-D0318ED7FF65

P577

Q28254373-3D2FA146-40DE-43AC-BEB3-D1D68E25D65E

P5875

Q28254373-C73732D4-3464-4E2C-B9BD-FDAF8ABF2833

P698

Q28254373-8771F4DB-08DB-448B-B057-643A5E930528

P921

Q28254373-0D822169-E527-42D3-9909-29690D5EDBA2

P932

Q28254373-3873B420-66EA-4DB9-83D0-95CE40B5F996

P356

P1433

Journal of Clinical Investigation

P1476

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

@en

P2093

A Sjoerdsma

http://www.w3.org/2001/XMLSchema#string

D Horwitz

http://www.w3.org/2001/XMLSchema#string

E Jéquier

http://www.w3.org/2001/XMLSchema#string

K Engelman

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.

ELEVATED PLASMA FREE FATTY ACID CONCENTRATIONS IN PATIENTS WITH PHEOCHROMOCYTOMA. CHANGES WITH THERAPY AND CORRELATIONS WITH THE BASAL METABOLIC RATE.

BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE.

Toxicologic studies with alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.

Increased synthesis of norepinephrine in the rat heart on electrical stimulation of the stellate ganglia.

P304

577-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI105754

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

1968-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17549167

http://www.w3.org/2001/XMLSchema#string

P698

5637145

http://www.w3.org/2001/XMLSchema#string

P921

P932

297204

http://www.w3.org/2001/XMLSchema#string